Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AOD 9604 affects fat metabolism, but does not suppress appetite like other medications for weight loss
At a concentration of 30 M, it inhibited more than 70% of adipogenesis and significantly reduced intracellular triglyceride accumulation
Subcutaneous injection delivers peptide directly into systemic circulation
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
In rodent studies, researchers have evaluated AOD 9604 for its impact on stored fat deposits, particularly in visceral and abdominal regions
Early preclinical data suggests it may influence neurovascular stability and axonal regeneration pathways, making it of interest in neural injury research [5]
US$ 26.23
US$ 24.74
US$ 27.84
